Discover 1,289 paid clinical trials in Columbus, Ohio. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Columbus hosts a variety of active clinical studies, including for conditions such as diabetes, asthma, and cardiovascular diseases. The city's prominent healthcare institutions are recruiting participants, both as healthy volunteers seeking paid research opportunities and individuals in need of trials for specific conditions, offering access to new and innovative treatments and therapies.
Filter
2
Filter results
Results: 1,289
Active & ResponsiveNew
Alternating Chemo-immunotherapy and FGFR Inhibitor for FGFR-positive Biliary or Cholangiocarcinoma
for
Locally Advanced Ampulla of Vater Carcinoma,
Location: Columbus OH
Sponsor: Ohio State University Comprehensive Cancer Center
Sex: All
Age: 18+
Code: NCT07780838
Phase2, Recruiting
Active & ResponsiveNew
Ziftomenib for the Treatment of Patients With NPM1 Mutated or KMT2A Rearranged Acute Myeloid Leukemia Not Eligible for Standard Therapy
for
Acute Myeloid Leukemia
Location: Columbus OH
Sponsor: Uma Borate
Sex: All
Age: 18+
Code: NCT06930352
Phase2, Recruiting
Active & ResponsiveNew
Venetoclax Plus Zanubrutinib for the Treatment of Chronic Lymphocytic Leukemia and Small Lymphocytic Lymphoma
for
Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma
Location: Columbus OH
Sponsor: Kerry Rogers
Sex: All
Age: 18+
Code: NCT07734038
Phase2, Recruiting
Active & ResponsiveNew
The Abuse Liability of IQOS Heated Tobacco Products Among Adults Who Smoke
for
Tobacco
Location: Columbus OH
Sponsor: Ohio State University Comprehensive Cancer Center
Sex: All
Age: 21 - 65
Code: NCT07688304
Recruiting
Active & Responsive
Low Dose Tamoxifen With or Without Omega-3 Fatty Acids for Breast Cancer Risk Reduction
for
Breast Atypical Hyperplasia, Breast Carcinoma,
Location: Columbus OH, Ann Arbor MI, Kansas City KS
Sponsor: National Cancer Institute (NCI)
Sex: Female
Age: 45 - 70+
Code: NCT06195306
Phase2, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Active & Responsive
Solid Tumor Analysis for HLA Loss of Heterozygosity (LOH) and Apheresis for CAR T- Cell Manufacturing
for
Solid Tumor, Adult, Colorectal Cancer,
Location: Columbus OH, Nashville TN, St Louis MO, New York NY,
Sponsor: A2 Biotherapeutics Inc.
Sex: All
Age: 18+
Code: NCT04981119
Recruiting
Active & Responsive
A Study of NovoTTF-200T(P) in Combination With Gemcitabine and Nab-Paclitaxel for Resectable Pancreatic Adenocarcinoma
for
Pancreatic Adenocarcinoma, Resectable Pancreatic Cancer
Location: Columbus OH
Sponsor: Ashish Manne
Sex: All
Age: 18+
Code: NCT05624918
Phase2, Recruiting
Active & Responsive
A Study to Evaluate the Safety and Efficacy of Mesothelin-Targeting Logic-gated CAR T, in Participants With Solid Tumors That Express MSLN and Have Lost HLA-A*02 Expression
for
Solid Tumor, Adult, Colorectal Cancer, NSCLC,
Location: Columbus OH, Nashville TN, St Louis MO, New York NY,
Sponsor: A2 Biotherapeutics Inc.
Sex: All
Age: 18+
Code: NCT06051695
Phase1, Phase2, Recruiting
Active & Responsive
Designing a Dyad-Based mHealth Intervention to Improve Adherence to Lifestyle Recommendations in Colorectal Cancer Survivors and Their Family Caregivers
for
Stage I Colon Cancer AJCC v8, Stage I Rectal Cancer AJCC v8,
Location: Columbus OH
Sponsor: Ohio State University Comprehensive Cancer Center
Sex: All
Age: 18+
Code: NCT06746012
Recruiting
Active & Responsive
Zanubrutinib and Lisocabtagene Maraleucel for the Treatment of Richter's Syndrome
Location: Columbus OH, Hillsborough NC, New Brunswick NJ,
Sponsor: Timothy Voorhees
Sex: All
Age: 18+
Code: NCT05786040
Phase2, Recruiting
Active & Responsive
Acolbifene Versus Low Dose Tamoxifen for the Prevention of Breast Cancer in Premenopausal Women at High Risk for Development of Breast Cancer
for
Breast Atypical Hyperplasia, Breast Carcinoma,
Location: Columbus OH, Chicago IL, Kansas City KS, Duarte CA
Sponsor: National Cancer Institute (NCI)
Sex: Female
Age: 35+
Code: NCT05941520
Phase2, Recruiting
Active & Responsive
A Study of Targeted Post-Surgery Radiation Therapy for Non-Small Cell Lung Cancer With Remaining Lymph Node Cancer After Treatment
for
Lung Non-Small Cell Carcinoma
Location: Columbus OH, Washington PA, Beaver PA, Pittsburgh PA,
Sponsor: Alliance for Clinical Trials in Oncology
Sex: All
Age: 18+
Code: NCT07293247
Phase2, Recruiting
Active & Responsive
A Phase 3 Study of Pelabresib (DAK539) and Ruxolitinib in Myelofibrosis (MF)
for
Primary Myelofibrosis (PMF),
Location: Columbus OH, Indianapolis IN, Atlanta GA,
Sponsor: Novartis Pharmaceuticals
Sex: All
Age: 18+
Code: NCT07357727
Phase3, Recruiting
Active & Responsive
A Study of Emavusertib + An Approved Bruton Tyrosine Kinase Inhibitor (BTKi) in Participants With Chronic Lymphocytic Leukemia (CLL) and Other B-cell Malignancies
for
Chronic Lymphocytic Leukemia, B-cell Malignancies
Location: Columbus OH, Pittsburgh PA, Florham Park NJ,
Sponsor: Curis, Inc.
Sex: All
Age: 18+
Code: NCT07271667
Phase2, Recruiting
Active & Responsive
Testing the Combination of an Anti-cancer Drug, Iadademstat, With Other Anti-cancer Drugs (Atezolizumab or Durvalumab) at Improving Outcomes for Small Cell Lung Cancer
for
Extensive Stage Lung Small Cell Carcinoma,
Location: Columbus OH, Cincinnati OH, West Chester OH,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 18+
Code: NCT06287775
Phase1, Phase2, Recruiting
Active & Responsive
Tebentafusp Regimen Versus Investigator's Choice in Previously Treated Advanced Melanoma (TEBE-AM)
Futibatinib in Combination With Durvalumab Prior to Cystectomy for the Treatment of Muscle-Invasive Bladder Cancer Patients Who Are Ineligible for Cisplatin-based Therapy